ClinicalTrials.govpublic full text
A Study for G1b CHC Patients With CKD-3 Treated With Grazoprevir Plus Elbasvir
hepatitis c viral, chronic kidney disease stage3, direct acting antivirals, grazoprevir, elbasvir, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 969835
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.